AI may allow safer breast MRIs with lower contrast doses

This study tested whether artificial intelligence (AI) can help doctors accurately identify breast tumors on MRIs that use a lower dose of gadolinium contrast dye. Reducing the dose may lower the amount of gadolinium deposited in the brain. The study included 20 women—half with breast cancer and half with benign findings—and compared low-dose images to standard-dose images using AI assistance.